PROBABILITY OF ACHIEVING LOW DISEASE ACTIVITY AT 52 WEEKS IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH CERTOLIZUMAB PEGOL DEPENDS ON TIME TO AND LEVEL OF INITIAL RESPONSE
Author(s):
Heijde, D. van der; Schiff, M.; Keystone, E.; Landewe, R.; Kvien, T.; Curtis, J.; Khanna, D.; Luijtens, K.; Furst, D.
